Dental: Medication-Related Damage to Oral Hard and Soft Tissues

19.95
Online
Elective
Please select your state to enroll in this course
About the Course: 
The purpose of this basic-level course is to prepare dentists, dental hygienists, and dental assistants to identify these medication-related adverse effects and treat or assist in treating them. This course begins by presenting conditions involving damage to the hard dental structures caused by fluoride, anticonvulsants, chemotherapeutics, and medications such as bisphosphonates that are associated with osteonecrosis of the jaw. Tooth discoloration is also discussed. Damage to oral soft tissues is then reviewed. Color changes to the oral mucosa, including mucosal pigmentation and black hairy tongue, are described. Drug-related gingival enlargement and other mucosal disorders, oral allergic reactions, drug-related white lesions, and conditions of the salivary glands are examined. 

Course Objectives: 
After completing this course, the learner will be able to: 
1. Identify common chemical- and medication-related damage to oral hard tissues and their dental management. 
2. Identify common damage to oral soft tissues resulting in color changes to the oral mucosa. 
3. Describe drug-related effects on the oral soft tissues, including gingival enlargement, mucosal disorders, white lesions, and salivary gland disorders. 
4. Recognize drug-related changes to salivary glands and how to manage these effects. 

About the Author: 
Mark Donaldson, BSP, RPH, PharmD, ACPR, FASHP, FACHE, received his baccalaureate degree from the University of British Columbia and his doctorate in clinical pharmacy from the University of Washington. He has further completed a residency at Canada’s largest tertiary care facility, Vancouver General Hospital, and is the current AVP of Pharmacy Consulting Services at Vizient. Dr. Donaldson is a clinical professor in the Department of Pharmacy at the University of Montana in Missoula, and clinical associate professor in the School of Dentistry at the Oregon Health & Science University in Portland. He has a special interest in dental pharmacology and has lectured internationally to both dental and medical practitioners. Dr. Donaldson has a number of published works in the peer-reviewed literature and has co-authored textbook chapters. He spent three years in Japan focusing on cross-cultural communication and internationalization. He currently serves on the Editorial Board for The Journal of the American Dental Association (JADA), is board-certified in healthcare management, and is the past-president and current Regent of the American College of Healthcare Executives’ Montana Chapter. In 2016 he was recognized by the Academy of General Dentistry as the recipient of the Dr. Thaddeus V. Weclew Award. This award is conferred upon an individual who has made outstanding contributions to the art and science of dentistry and/or enhanced the principles and ideals of the Academy. In 2019 he was awarded the, “Special Friend of Canadian Dentistry Award,” by the Canadian Dental Association (CDA) in Ottawa. This international award is given to an individual outside of the dental profession in appreciation for exemplary support or service to Canadian dentistry and/or to the profession as a whole. 

AGD code - 741

Course Disclosures

  • Courses must be completed on or before the course expiration date.
  • You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
  • Through our review processes, Elite ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Elite's policy not to accept commercial support.
  • All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.
  • There are no prerequisites for this course.
Want Unlimited CE? Become a Member

Medication-Related Damage to Oral Hard and Soft Tissues

19.95
About the Course: 
The purpose of this basic-level course is to prepare dentists, dental hygienists, and dental assistants to identify these medication-related adverse effects and treat or assist in treating them. This course begins by presenting conditions involving damage to the hard dental structures caused by fluoride, anticonvulsants, chemotherapeutics, and medications such as bisphosphonates that are associated with osteonecrosis of the jaw. Tooth discoloration is also discussed. Damage to oral soft tissues is then reviewed. Color changes to the oral mucosa, including mucosal pigmentation and black hairy tongue, are described. Drug-related gingival enlargement and other mucosal disorders, oral allergic reactions, drug-related white lesions, and conditions of the salivary glands are examined. 

Course Objectives: 
After completing this course, the learner will be able to: 
1. Identify common chemical- and medication-related damage to oral hard tissues and their dental management. 
2. Identify common damage to oral soft tissues resulting in color changes to the oral mucosa. 
3. Describe drug-related effects on the oral soft tissues, including gingival enlargement, mucosal disorders, white lesions, and salivary gland disorders. 
4. Recognize drug-related changes to salivary glands and how to manage these effects. 

About the Author: 
Mark Donaldson, BSP, RPH, PharmD, ACPR, FASHP, FACHE, received his baccalaureate degree from the University of British Columbia and his doctorate in clinical pharmacy from the University of Washington. He has further completed a residency at Canada’s largest tertiary care facility, Vancouver General Hospital, and is the current AVP of Pharmacy Consulting Services at Vizient. Dr. Donaldson is a clinical professor in the Department of Pharmacy at the University of Montana in Missoula, and clinical associate professor in the School of Dentistry at the Oregon Health & Science University in Portland. He has a special interest in dental pharmacology and has lectured internationally to both dental and medical practitioners. Dr. Donaldson has a number of published works in the peer-reviewed literature and has co-authored textbook chapters. He spent three years in Japan focusing on cross-cultural communication and internationalization. He currently serves on the Editorial Board for The Journal of the American Dental Association (JADA), is board-certified in healthcare management, and is the past-president and current Regent of the American College of Healthcare Executives’ Montana Chapter. In 2016 he was recognized by the Academy of General Dentistry as the recipient of the Dr. Thaddeus V. Weclew Award. This award is conferred upon an individual who has made outstanding contributions to the art and science of dentistry and/or enhanced the principles and ideals of the Academy. In 2019 he was awarded the, “Special Friend of Canadian Dentistry Award,” by the Canadian Dental Association (CDA) in Ottawa. This international award is given to an individual outside of the dental profession in appreciation for exemplary support or service to Canadian dentistry and/or to the profession as a whole. 

AGD code - 741

Course Disclosures

  • Courses must be completed on or before the course expiration date.
  • You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
  • Through our review processes, Elite ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Elite's policy not to accept commercial support.
  • All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.
  • There are no prerequisites for this course.